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a  b  s  t  r  a  c  t
Fasciola  hepatica  is  a common  parasite  in cattle,  and  bovine  fasciolosis  causes  signiﬁcant
production  losses,  as well  as  being a zoonotic  disease  of  global  importance.  F.  hepatica  has
been shown  to  have immunoregulatory  effects  and the aim  of  this  research  was  to estab-
lish whether  F. hepatica  infection  inﬂuences  the  response  to vaccination  against  respiratory
pathogens  in  calves.  A  total  of  48  calves  were  randomly  and equally  allocated  to two  groups.
The experimental  group  was infected  with  F. hepatica,  while  the  other  group  was  used as
a control.  At  week  2 and  6 after  infection  calves  from  both  groups  were administered  a
vaccine containing  inactivated  PI-3, BRSV  and Mannheimia  haemolytica, pathogens  com-
monly associated  with  bovine  respiratory  disease.  Blood  samples  were  taken  weekly over
12  weeks  to measure  speciﬁc  antibodies  against  all  vaccine  antigens  and  against  F. hepat-
ica,  as  well  as  IgG1  and  IgG2  isotypes  for PI-3  and BRSV  speciﬁc  antibodies.  Faecal  samples
were  examined  for F.  hepatica  eggs  and routine  haematology  and  liver  enzyme  biochemistry
were  performed  and  cytokine  production  in  vitro  measured.  Liver  enzymes  (GGT  and  GLDH)
and eosinophils  were  signiﬁcantly  higher  in the experimental  group,  whereas  neutrophil
numbers  were  higher  in  the  control  group.  There  was no signiﬁcant  difference  between  the
groups  in  terms  of  vaccine-speciﬁc  total  responses  to PI-3, BRSV  and  M.  haemolytica.  IgG1
levels were  higher  in comparison  to IgG2  levels  in both  PI-3  and  BRSV  speciﬁc  antibodies.
IL-4  levels  from  stimulated  and  unstimulated  PBMC  were  signiﬁcantly  higher  in  the  control
group. IFN-  levels  were  signiﬁcantly  higher  in PBMC  from  the  control  group  when cultured
in medium  only.  No  signiﬁcant  differences  were  noted  in the  levels  of  other  cytokines  mea-
sured. In this  work,  no  effect  of  early  F. hepatica  infection  on the  antibody  responses  to  a
range of respiratory  vaccine  antigens  in  calves  was  shown.  However,  differences  in cytokine
responsiveness  of  PBMC  between  control  and  infected  groups  were  observed,  indicating
that  further  work  in  measuring  the  effect  of F.  hepatica  infection  response  to challenge
infection  following  vaccination  would  be warranted.
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1. Introduction
Vaccines are an important tool in livestock production,
Open access under CC BY-NC-SA license.not only as a means of maintaining health and freedom
from clinical diseases, but also in some cases as a means
of preventing zoonotic disease and thus enhancing food
safety and public health.
-NC-SA license.
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Bovine respiratory disease (BRD) in calves and young
cattle is a signiﬁcant source of morbidity and mortality, and
is a major contributing factor for economic losses in cat-
tle industry (Snowder et al., 2006). BRD is a multifactorial
disease (Babiuk et al., 1988); the most common bacterial
pathogens associated with it are Mannheimia haemolytica,
Pasteurella multocida,  Mycoplasma bovis as well as various
viral pathogens; bovine respiratory syncytial virus (BRSV),
parainﬂuenza virus type 3 (PI-3), bovine viral diarrhoea
virus (BVDV) and bovine herpes virus type 1 (BHV-1). Even
though there is limited published information that deﬁni-
tively establishes the efﬁcacy of respiratory vaccines in the
ﬁeld in reducing the burden of bovine respiratory disease
(Perino and Hunsaker, 1997), vaccinations against one or
more of the respiratory pathogens are commonly used.
Helminth infections can inﬂuence the immune response
to unrelated antigens (Kullberg et al., 1992). Furthermore,
they have been shown to decrease the response to vaccina-
tions in various host species (Elias et al., 2001; Urban et al.,
2007). Fasciola hepatica, a helminth parasite, causes fasci-
olosis in cattle and sheep and fasciolosis is also a zoonosis.
It is a common parasite, especially in the temperate cli-
mate of the UK and Ireland, where the prevalence in cattle
is as high as 84% (McCann et al., 2010). F. hepatica has been
proven to have immunoregulatory effects in mice (Brady
et al., 1999). In cattle, it can alter the response to immune-
mediated diagnostic tests (Flynn et al., 2007) but its effect
on vaccine responsiveness in this species has not yet been
studied.
The aim of this study was to establish whether a concur-
rent F. hepatica infection inﬂuences the immune response
induced by vaccination against respiratory pathogens in
calves. This study was undertaken in an effort to measure
the extent to which helminth-mediated immunoregulation
may  have a demonstrable effect on the host’s ability to con-
trol other diseases which are economically important in
livestock.
2. Materials and methods
2.1. Experimental design
Castrated male Holstein–Friesian calves (n = 48), aged
3–7 months, were used in the study. The calves were
kept indoors at University College Dublin Lyons Research
Farm under normal husbandry conditions. All experimen-
tal procedures were approved by the UCD Animal Ethics
Committee and under licence from the Department of
Health, Dublin, Ireland (reference number B100/4399).
All animals were administered ivermectin (Noromectin,
Norbrook) prior to the commencement of the trial (as per
manufacturer’s guidelines). Initial serological and faecal
analyses, performed two weeks prior to commencement
of the trial were used to determine any previous exposure
to the viral respiratory pathogens (PI-3 and BRSV) and
F. hepatica, respectively. The calves with no previous
exposure to liver ﬂuke infection were then randomly
allocated to one of two groups—an experimental group
which was infected with F. hepatica by the administration
of 150 viable metacercariae (Ridgeway Research, Lydney,
Gloucestershire, UK) resuspended in distilled water per ostology 201 (2014) 31–39
at the commencement of the study (week 0 of the trial),
and a second group used as a control. Four animals which
were seropositive for liver ﬂuke at the beginning of the trial
were automatically assigned to the experimental group.
Two  weeks later (week 2 of the trial), following the
establishment of a ﬂuke infection, calves from both groups
were administered 5 ml  of Bovipast RSP vaccine (MSD
Animal Health) containing inactivated PI-3, BRSV and M.
haemolytica in accordance with the manufacturer’s guide-
lines. A booster vaccination was administered four weeks
later (week 6 of the trial).
2.2. Faecal egg count (FEC)
Faeces were sampled from the rectum of each animal
prior to commencement of the study, and at weeks 4 and
12 of the trial. Identiﬁcation and counts of F. hepatica eggs
in 3 g of faecal material were carried out using the sedi-
mentation technique (Cawdery and Ruane, 1971).
2.3. Haematology and biochemistry
Blood sampling of all animals was  carried out weekly
from week 2 of the trial; 2 weeks post infection, using EDTA
vaccutainers for haematology and uncoated vaccutainers
for biochemistry. Total cell counts were measured using an
Advia 2120 Analyzer (Siemens). Serum gamma  glutamyl-
transferase (GGT) and glutamate dehydrogenase (GLDH)
levels were measured using an Imola Clinical Chemistry
Analyzer (Randox).
2.4. Serological analysis
Blood samples from all animals were collected into
uncoated tubes for serological examination (ELISA and
serum neutralisation test), in accordance with the pro-
cedures outlined below. Sampling was carried out on a
weekly basis starting at week 2 (the day of 1st vaccination).
2.4.1. ELISA for detection of F. hepatica antibodies
Blood samples were centrifuged at 1900 × g for 5 min
and the serum removed. The speciﬁc antibody response
to the F. hepatica infection was measured by ELISA using
rmFhCL1 as antigen and a monoclonal anti-bovine IgG1
as previously described by Golden et al. (2010) with
some modiﬁcations. Brieﬂy, 96-well plates were coated
with 1 g/well of rmFhCL1 overnight at 37 ◦C. Phosphate
buffered saline with tween (0.05% PBST) was used as block-
ing buffer and 1% bovine serum albumin (BSA) in 1%
BSA–PBS was used as blocking and dilution buffer.
Serum dilutions (1:20) were added in duplicate to the
plate (100 l per well) and incubated for 30 min  at 37 ◦C.
Bound antibody was  detected by addition of a monoclonal
anti-bovine IgG1-HRP conjugated antibody (Prionics),
diluted 1:100, followed by 3,3,5,5-tetramethylbenzidine
(TMB-Sigma). Absorbances were read at 450 nm on an
Expert 96 Microplate reader (Biochrom).2.4.2. Serum neutralisation test (SNT) for BRSV and PI-3
Double dilutions of inactivated sera were made in
a 96-well ﬂat-bottomed cell-culture grade microtitre
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late. After incubation with virus for 24 h at 37 ◦C a cell
uspension of foetal bovine kidney cells was added. After
ncubation for 3–5 days at 37 ◦C, the plates were read
icroscopically for cytopathic effects (CPE). The test
erum results were expressed as the reciprocal of the
ilution of serum that neutralised the virus in 50% of the
ells. If 50% of the wells with undiluted serum neutralised
he virus, the (initial dilution) titre was read as 1 (1:2 using
he ﬁnal dilution convention). If all the undiluted and 50%
f the wells with 1:2 diluted serum neutralised the virus,
he (initial dilution) titre was 2 (ﬁnal dilution 1:4).
.4.3. ELISA for detection of PI-3 and BRSV speciﬁc
ntibodies
Serum antibody levels to BRSV and PI-3 were evaluated
sing the commercial indirect IgG ELISAs Svanovir BRSV-Ab
nd Svanovir PI-3-Ab, respectively (Svanova Biotech, Upp-
ala, Sweden). Both the ELISA testing procedure and the
nterpretation of results were performed according to the
anufacturer’s instructions. Sera were tested at a dilution
f 1:25 and results reported as percent positivity values
PP), calculated in respect to a common positive control.
.4.4. ELISA for detection of IgG1 and IgG2 isotypes
Antibody isotypes for PI-3 and BRSV were measured at
eek 2, 4, 7, 9 and 12 using bovine parainﬂuenza virus type
 (Svanovir PIV3-Ab) and bovine respiratory syncytial virus
Svanovir BRSV-Ab) antibody test kits from Boehringer-
ngelheim Svanova (Uppsala, Sweden). Sera were diluted
:25 (total volume was 100 l) in PBST (0.01%), and plates
ere incubated at 37 ◦C for 1 h. Plates were washed three
imes in PBST, and tapped to remove excess liquid. Con-
ugate (100 l) was added and plates were incubated at
7 ◦C for 1 h. For the IgG1 ELISA, the anti-bovine HRP con-
ugate was used as provided. For the IgG2 ELISA, a mouse
nti-bovine IgG2 HRP conjugate (ABD Serotec, Kidling-
on, UK) was substituted for the kit reagent and used at
 dilution of 1:500. Plates were washed three times in
BST and TMB  substrate was added, with incubation at
oom temperature for 10 min. Development of the solu-
ion was stopped and the plates were read at 450 nm
sing an LED96 Detect plate reader (Dynamica Scientiﬁc,
ilton Keynes, UK). Corrected optical density readings
ere calculated by subtracting the plate background read-
ng.
.4.5. ELISA for detection of M.  haemolytica speciﬁc
ntibodies
Antibodies speciﬁc for M.  haemolytica were measured
t week 2, 6, 10 and 12 with an in-house ELISA at the
aboratory of MSD  Animal Health (Boxmeer, Netherlands).
icrotitre plates were coated with M.  haemolytica antigen.
erum was diluted and incubated and bound antibodies
ere detected after incubation with an anti-bovine serum-
eroxidase conjugate as previously described (Assié et al.,
009)..5. Cytokine expression
At weeks 8 and 12, blood samples from a subset of
alves (six randomly selected animals from each group)tology 201 (2014) 31–39 33
were collected into heparinized tubes. Peripheral blood
mononuclear cells (PBMC) were isolated by centrifug-
ing over Histopaque (Sigma) and recovered in RPMI
1640 medium (supplemented with 10% heat-inactivated
foetal calf serum, 100 U/ml penicillin, 100 g/ml strepto-
mycin, 2 mM l-glutamine). Viable cells were counted by
Trypan blue exclusion and resuspended at a concentra-
tion of 1 × 106 cells/ml. One millilitre of this suspension
was added in duplicate to a 24-well plate. Cells were
stimulated with F. hepatica excretory-secretory antigen
(ES; 10 g/ml), lipopolysaccharide (LPS; Escherichia coli
0111:B4, Alexis; 5 g/ml) as a bacterial antigen and
toll-like receptor ligand 7/8 (TLRL; Resiquimod R848,
Invivogen; 1 mg/ml) as a viral antigen. Medium and Con
A (Sigma; 5 g/ml) were used as negative and posi-
tive controls, respectively. Cell cultures were incubated
for 72 h at 37 ◦C before supernatants were collected and
stored at −20 ◦C for cytokine analysis. Cytokine levels
were measured using commercially available ELISA kits,
or antibody pairs. Interleukin 4 (IL-4) was  measured
using a kit from Pierce Biotechnology in accordance with
the manufacturer’s guidelines. Transforming growth fac-
tor beta (TGF-) was measured using a human ELISA
(Promega) as previously described (Abbott et al., 2005).
Nitric oxide (NO) was measured using the Griess Reagent
Kit (Promega). Interleukin 10 (IL-10) and Interferon gamma
(IFN-) were measured using commercially available anti-
body pairs as previously described (Flynn and Mulcahy,
2008).
2.6. Statistical analysis
Regression procedures were employed to compara-
tively assess the effect of liver ﬂuke infection status on each
of the vaccination, biochemical and cytokine variables, over
a 12-week period.
Prior to the analysis, the stability of the variance for
each parameter was assessed, and where normality was
not identiﬁed, a transformation step was applied (log trans-
formed for PI-3 and BRSV SNT as well as GLDH and square
root transformed for GGT variables). In the case of IFN-
and BRSV, where the variance for these dependent vari-
ables could not be stabilised, a non-parametric quartile
(median 50) regression model was  applied.
In addition, a pre-infection comparison of all variables
was carried out using an independent student t-test to
ensure a group effect was not present prior to commence-
ment of the trial. In cases where a P value of ≤0.20
was identiﬁed (indicating the potential for a pre-infection
group effect), the pre-infection values were subtracted
from all subsequent data points in order to standardise the
group comparison. This adjustment was applied to both
BRSV ELISA and BRSV SNT variables.
Regression models were constructed (8 for haematology
and biochemistry and 9 for vaccine data), each assessing the
combined effect of group, duration, and group by duration
interaction on the dependent variable. p values of ≤0.05
were considered statistically signiﬁcant. All statistical anal-
ysis was performed using Stata/SE v12.1 (StataCorp, Texas,
USA).
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3. Results
3.1. Faecal analysis
The analysis prior to the trial and at week 4 of the trial
revealed no ﬂuke eggs present in any of the animals. At
week 12 post infection (p.i.), four of the 24 calves in the
experimental group had a positive faecal egg count, 2 eggs
were identiﬁed in one sample (3 g) and 1 egg each in the
remaining three. None of the four animals that were posi-
tive for ﬂuke antibodies before the trial had a positive faecal
egg count. All animals in the control group were negative
for F. hepatica eggs throughout the experiment.
3.2. Haematology and biochemistry
The results of the haematology analysis showed a
signiﬁcant difference between the groups for absolute
eosinophil and absolute neutrophil numbers, as presented
in Fig. 1A and B. Absolute eosinophil numbers were sig-
niﬁcantly higher (p ≤ 0.001) in the infected group at 4,
5, 6, 8 and 10 weeks p.i. (one animal was identiﬁed as
an outlier because of signiﬁcantly higher values through-
out the experiment and was excluded from the analysis).
Peak eosinophil counts occurred at week 5 p.i. Mean
neutrophil numbers of all calves (n = 48) were above the
reference range (0.6–4 × 109 L−1) prior to the experiment
Fig. 1. Haematology and biochemistry results (mean ± SEM) for both groups th
metacercariae at week 0. Vaccination for PI-3, BRSV and M. haemolytica occurre
≤0.001. The line (----) represents the upper reference limit; (A) absolute eosinoph
to  stabilise the variance) and (D) GGT (data was square rooted to stabilise the vartology 201 (2014) 31–39
and declined thereafter. Absolute neutrophil counts were
signiﬁcantly higher in the control group at 2, 7, 9 and 10
weeks p.i., with the overall model construct, accounting for
group and time effects, indicating a signiﬁcant difference
(p = 0.004) between the groups. No signiﬁcant differences
were measured in the number of lymphocytes, basophils
or monocytes (data not shown).
The results of the biochemistry analysis indicated signif-
icantly elevated liver speciﬁc enzymes, GLDH (p ≤ 0.001)
and GGT (p ≤ 0.001) in the experimental group, as pre-
sented in Fig. 1C and D. The difference between the groups
for GLDH was apparent by week 5 p.i., and persisted
throughout. For GGT, the difference was apparent by week
8 p.i., and also persisted throughout.
3.3. Serological analysis
3.3.1. ELISA for detection of F. hepatica antibodies
Prior to the commencement of the experiment, 4 out
of 48 calves were positive for anti F. hepatica antibodies
(above the cut-off value of 20 PP), which were therefore
allocated to the experimental group. A total of 21 of the
24 animals in the experimental group were positive by 4
weeks p.i., with all 24 animals seroconverted by week 6
and remained positive until the end of the study. All of the
animals in the control group were negative for F. hepatica
antibodies throughout the experiment.
roughout the experiment. The infected group were infected with 150
d at week 2 and 6 (→). * indicates p-value ≤0.05, *** indicates p-value
il numbers; (B) absolute neutrophil numbers; (C) GLDH (data was logged
iance).
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Fig. 2. Serological evaluation of responses to respiratory vaccines (mean ± SEM) for both groups. Vaccination for PI-3, BRSV and M.  haemolytica occurred
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it  week 2 and 6 (→). (A) SNT results showing PI-3 speciﬁc antibody titres
C)  ELISA results showing PI-3 antibody titres (percentage positive values
itres  (percentage positive values). The line (----) represents the cut-off; (
.3.2. Serum neutralisation test for PI-3 and BRSV
peciﬁc antibodies
The results of the SNT for PI-3 and BRSV are presented
n Fig. 2A and B. At the initial examination (week −2), the
ean log titre of PI-3 and BRSV speciﬁc antibodies of all
alves from both groups was 1.7 ± 0.08 and 0.45 ± 0.07,
espectively. The PI-3 SNT proﬁle indicated a comparable
ntibody proﬁle between both groups, with no signiﬁcant
ifference identiﬁed (p = 0.18). Antibody levels increased
apidly for both groups at week 3 p.i. (one week follow-
ng 1st vaccination) and remained elevated with minorlues); (B) SNT results showing BRSV speciﬁc antibody titres (log values);
ne (----) represents the cut-off; (D) ELISA results showing BRSV antibody
 results showing M. haemolytica speciﬁc antibodies (log 2 values).
variations throughout. The BRSV SNT proﬁle also indicated
no differences between the groups (p = 0.62). Antibody
titres ﬂuctuated similarly for both groups, with rising titres
mainly correlating with the vaccination protocol with the
exception of low values at week 9.
3.3.3. ELISA for detection of PI-3 and BRSV speciﬁc
antibodies
ELISA results showed all animals were positive for
PI-3 antibodies (cut-off value at 10 PP) with a mean value
of 109.8 ± 6.7 PP and 36 (75%) were positive for BRSV
36 L. Krump et al. / Veterinary Parasitology 201 (2014) 31–39
 and IgGFig. 3. Antibody isotype measurements for PI-3 and BRSV; Levels of IgG1
(→)  represent the time point of vaccination, * indicates p-value ≤0.05.
antibodies (cut-off value at 10 PP) with a mean value of
56.3 ± 7.1 PP prior to the vaccination.
ELISA results for PI-3 are presented in Fig. 2C and these
indicate that antibody titres were not signiﬁcantly differ-
ent between the groups, and the proﬁle of antibody changes
over time were identical. There was an increase in antibody
levels following primary vaccination (week 2 p.i.), with a
steady decline following week 8. The ELISA results for BRSV
(Fig. 2D) indicate increasing antibody levels following pri-
mary vaccination (week 2 p.i.), a steady increase to week
10 and then a decline. There was no difference between
groups in either case, with a p-value of 0.81 for BRSV and
0.55 for PI-3.
3.3.4. ELISA for detection of M.  haemolytica speciﬁc
antibodies
Antibody titres speciﬁc to M.  haemolytica are presented
in Fig. 2E, which shows there was no difference between the
groups (p = 0.26). Animals from both groups showed high2 for PI-3 (mean ± SEM) (A) and for BRSV (mean ± SEM) (B). The arrows
antibody titres on the day of vaccination, which increased
over time with a peak at week 10.
3.3.5. ELISA for IgG1 and IgG2 isotypes
Levels of IgG2 were lower in comparison to IgG1 for
both PI-3 (Fig. 3A) and BRSV (Fig. 3B). There was a signiﬁ-
cant difference (p = 0.01) between the groups for BRSV IgG1
antibodies at week 4 but the difference was not evident
thereafter. Levels of IgG1 for BRSV reached their peak at
week 9, whereas levels of IgG1 for PI-3 peaked at week 4
and gradually declined thereafter. On the other hand, levels
of IgG2 for BRSV were lowest at week 4 and at week 2 for
PI-3 but no group effect was identiﬁed for any of the IgG2
levels.3.4. Cytokine expression
In vitro cytokine analysis indicated that the production
of IFN- by PBMC was signiﬁcantly higher (p = 0.048 for
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Fig. 4. Cytokine expression (mean ± SEM) by PBMCs, re-stimulated in vitro, from a subset of calves from both groups (n = 12) at week 8 and 12 after
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rnfection with F. hepatica. * indicates p-value ≤0.05, ** indicates a p-value
L-4  production (pg/ml) from unstimulated cells; (C) IL-4 production (pg
ith  LPS.
he overall model) in calves from the control group when
he cell culture was not stimulated with antigens (Med) as
hown in Fig. 4A.
At week 8, IL-4 production was signiﬁcantly higher
p = 0.03) in the control group from unstimulated cells
Fig. 4B). At week 12 the concentration of IL-4 was sig-
iﬁcantly higher (p = 0.04) in the control group from cells
timulated with TLRL 7/8 (Fig. 4C) as well as from cells
timulated with LPS (p = 0.06) as shown in Fig. 4D.
No signiﬁcant differences between groups were noted
n IL-10, TGF- and NO production, although there was  a
esponse to all antigens in these cytokines, as well as pro-
uction from unstimulated PBMC (data not presented).
. Discussion
The purpose of this study was to establish if the
mmunomodulatory effects of liver ﬂuke infection in cattle
an affect the host response to bacterial and viral vac-
ination. The effects of helminth infection on the host
mmune system have been well characterised, and can
e summarised by an increase in the production of Th2
nd regulatory T cell cytokines, with an associated nega-
ive feedback on Th1 cells (McSorley and Maizels, 2012). F.
epatica infection in cattle has a similar effect on the host
mmune system as other helminths (Flynn et al., 2010), and
n previous studies in mice (O’Neill et al., 2000) and cattle
Aitken et al., 1978) the immunosuppressive effects on the
esponse to other concurrent infections have been noted. (A) IFN- production (OD values) from unstimulated cells (medium); (B)
m cells stimulated with TLRL; (D) IL-4 production from cells stimulated
This study identiﬁed no alteration in the speciﬁc total
antibody response to BRSV, PI-3, and M.  haemolytica within
the ﬁrst 12 weeks of an experimental infection with F.
hepatica. In both groups the antibody proﬁles to BRSV, PI-
3, and M. haemolytica vaccination over time were similar.
This ﬁnding delivers reassurance that vaccination elicits
a comparable immune response despite concurrent infec-
tion. A single exception identiﬁed for IgG1 levels against
BRSV at week four indicates a potential group effect. How-
ever, this difference is no longer evident by week 7 and
thereafter, indicating that on a wider timescale, there is no
difference between the groups. Additionally, despite the
identiﬁcation of pre-existing antibodies to BRSV, PI-3 and
M. haemolytica, derived from either a maternal source or
previous exposure to the antigens, the calves from both
groups showed an initial increase in antibody levels after
vaccination. In contrast to convention that such antibod-
ies can have an inhibitory effect on the vaccine response
(Kimman and Westenbrink, 1990), this study demonstrates
a serological response to vaccination in the presence of pre-
existing antibodies. It remains to be determined whether
the antibody levels were sufﬁcient to prevent clinical out-
breaks of disease.
While our ﬁndings relate to F. hepatica infection, a sim-
ilar study also concluded that there were no effects of
Ostertagia ostertagi and Cooperia spp. infection on the respi-
ratory vaccine response in calves (Schutz et al., 2012).
However, these results are in contrast to other host species.
For example, helminth infection in the pig reduced the
y Parasi38 L. Krump et al. / Veterinar
efﬁcacy of vaccines against Mycoplasma hyopneumoniae
(Steenhard et al., 2009).
Adjuvants can have an important role in the success of
a vaccine. QuilA, the adjuvant used with this vaccine has
been previously shown to offset the immunomodulatory
effects of the ﬂuke, and to offer protective effect against F.
hepatica in sheep (Hac¸ arız et al., 2009). Similarly in this
study in cattle, it is plausible that the QuilA in the vac-
cine may  provoke an adequate immune response to viral
and bacterial infection despite concurrent infection with F.
hepatica.
It is also noteworthy that the immunoregulatory effects
described by Flynn et al. (2007) relates to the suppressive
effect of F. hepatica on the type IV delayed hypersensi-
tivity (antibody independent) reaction, as modelled on
the intradermal skin test. The vaccine used in this trial
has a combination of bacterial and viral antigens, which
is likely to induce a different immune response to that
caused by Mycobacterium bovis and therefore may  relate
to the difference between immune mechanisms involved
in an antibody independent hypersensitivity reaction and
an antibody dependent immune response to vaccination.
Relative to other comparable studies (Waldvogel et al.,
2004) where a higher dose of F. hepatica metacercariae
was used, the low dose used in this study could have
resulted in a parasite burden too low to have a demonstra-
ble effect on vaccine responsiveness. However, all animals
in the experimental group were infected, and did mount
an immunological response to liver ﬂuke infection as indi-
cated by seroconversion and increased liver enzymes. Low
number of calves with a positive faecal egg count reﬂects
the fact that the analysis was conducted early in the patent
period. Also, detection of F. hepatica eggs in bovine faeces is
a relatively insensitive diagnostic method (Anderson et al.,
1999).
The increase in eosinophils as well as liver enzymes was
signiﬁcantly higher in the experimental group relative to
the non-infected group, where no or little increase in these
parameters was identiﬁed. In contrast, neutrophil num-
bers, which were elevated relative to the reference range
at the start of the experiment, followed by a decline in both
groups, were signiﬁcantly lower in the infected group rel-
ative to the non-infected group. This observation in the
neutrophil count was in contrast to other studies (Egbu
et al., 2013) where a signiﬁcant increase was identiﬁed. A
reasonable explanation to account for this response is not
forthcoming. Stress, as a cause of the initial elevated num-
bers, is an unlikely explanation, given the animals were on
the farm for 2 months prior to the commencement of the
experiment. However, it is possible that an unknown sub-
clinical infection may  account for the unusual neutrophil
proﬁle, with the concurrent F. hepatica infection potentially
hampering the neutrophil response in the infected group.
The expected cytokine proﬁle following liver ﬂuke
infection of elevated Th2 and inhibited Th1 proﬁles was not
identiﬁed. In contrast to previous research, we found IL-4
concentrations produced by unstimulated and stimulated
PBMC to be higher in the control group. However, the levels
were very low, which could be partially due to the fact that
the peak production of IL-4 is at 4 to 6 weeks after infection
(Flynn and Mulcahy, 2008) whereas our measurementstology 201 (2014) 31–39
only took place at week 8 and 12 p.i. BRSV has the ability
to induce IL-4 production (Gershwin, 2012). If cells from
liver ﬂuke infected animals were hyporesponsive, it might
explain the higher IL-4 production in the control group. The
increased production of IFN- in the control group would
be indicative of a Th1 response, whereas calves infected
with F. hepatica had a lower Th1 response. However, the
surprisingly low IgG2 values after vaccination would be
indicative of decreased Th1 response in all animals regard-
less of the liver ﬂuke infection. This is in contrast to other
studies done with BRSV vaccination, where IgG2 levels
were as high as IgG1 (West and Ellis, 1997) even though
claims have been made that BRSV vaccination induces a
Th2 response in cattle (Kalina et al., 2004). IL-10 and TGF-
produced by regulatory T cells can play an important role
in maintaining parasite infections (Beiting et al., 2007). In
our case no signiﬁcant production of these cytokines in the
ﬂuke infected group was detected.
5. Conclusion
This study demonstrated that F. hepatica does not alter
the immunocompetence of calves to mount an immune
response to respiratory vaccination. Further studies includ-
ing challenge experiments would be required to establish
the impact of liver ﬂuke infection (acute as well as chronic)
on vaccination efﬁcacy and its effects on clinical signs, sur-
vival rate and potentially economic impact.
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